Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data. - Test2 - elhamkhani - TriplyDB

Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data.

Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data.

http://www.wikidata.org/entity/Q34043921

about

Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea.A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.Mefloquine in the nucleus accumbens promotes social avoidance and anxiety-like behavior in mice.Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.Paediatric travel medicine: vaccines and medications.Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique.Epilepsy triggered by mefloquine in an adult traveler to Uganda.Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.Current challenges in travelers' malaria.

P2860

Q28307141-371C37D2-B3DC-48DD-9FB1-DEE2EBC7C5C1 Q35029488-F76B6729-5287-4708-BDDD-AC7E9D8DED56 Q35500954-3F6E4D48-5F9B-4056-9CAB-C76E190FF63D Q35882507-5F978686-EBDA-4EA4-A999-7C058C4A1CFB Q36179156-69BD8DF6-9C01-4669-9616-37BDD74CED0E Q36377991-046096FC-45E6-477A-89B5-AE608EF6EC2C Q36561097-8CA0FC44-C8BD-424A-BEF5-251925D5C4DD Q36948104-85570BC1-5B89-4A45-AB72-11B23FF7EC65 Q37426125-3F9E2FCA-78C9-473C-BE92-004FA684C9AE Q37576127-75A50847-199B-4AE9-BF3A-D4264314CF75 Q38627882-4E0918C2-F217-4602-8415-20F077ADA40C Q45193734-65ABCA3F-2309-4D97-BBDF-5AE4AF72CC48

P2860

Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data.

http://www.wikidata.org/entity/Q34043921

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Use of mefloquine in children ...... inetics and tolerability data.

@ast

Use of mefloquine in children ...... inetics and tolerability data.

@en

Use of mefloquine in children ...... inetics and tolerability data.

@nl

type

label

Use of mefloquine in children ...... inetics and tolerability data.

@ast

Use of mefloquine in children ...... inetics and tolerability data.

@en

Use of mefloquine in children ...... inetics and tolerability data.

@nl

prefLabel

Use of mefloquine in children ...... inetics and tolerability data.

@ast

Use of mefloquine in children ...... inetics and tolerability data.

@en

Use of mefloquine in children ...... inetics and tolerability data.

@nl

P1433

Q34043921-5771FBC2-0181-4F4B-8699-69E43F5EB8A5

P1476

Q34043921-ACE11499-2483-49A3-9DF1-C6EAEA730CB0

P2093

Q34043921-1D161CA3-D989-494F-9AE8-6ECD73B0236F

Q34043921-1EA7F271-0311-4A7E-9EFB-F632D469CE99

Q34043921-478D0473-708B-48D9-97FE-B962D1D56F82

Q34043921-62493E1F-FF6C-4793-BB45-68B0B1CC5242

Q34043921-75CC8BDA-68EB-4417-95AE-CA864E908934

P275

Q34043921-156D3770-FBD8-4C45-A0B1-44C15C752455

P2860

Q34043921-08EE3345-ECD3-479E-8BD7-199EDEC9891C

Q34043921-1473FD15-66F3-4E19-9818-1602977B2173

Q34043921-1D60291C-ECC4-40CD-A4A7-0EFE079C189F

Q34043921-1FD5F992-ABC5-4F1A-A340-31B70F324C23

Q34043921-215E54DE-8DAE-4447-99AB-E046A70F0135

Q34043921-265DAD39-37B6-47D8-A061-F65BE26E0790

Q34043921-2BB8D9E0-1C0B-415C-AA9E-8AF22F8B22C5

Q34043921-323E0F6C-1F2F-4FB6-9C2C-D50ADBAF2166

Q34043921-33AE5A70-0341-4CB6-91F1-FAA0D43C9EC9

Q34043921-358FF65A-1EAA-4C1F-BFED-B7C46AE348C8

P2888

Q34043921-310C5204-C596-4C46-B456-72444AE2F2C0

P304

Q34043921-8AEA4EA2-46AD-46F7-A644-6F3572B8CD77

P31

Q34043921-DAECE40C-B1FE-4AAB-B76F-82C19B882C2F

Q34043921-FFB24048-AAB2-44DB-BCD4-4D296AB57578

P356

Q34043921-7AA66DC7-973C-4C06-99D7-45A270D4F666

P478

Q34043921-7C473312-0665-4EB5-AAA8-5EAAE99CA828

P50

Q34043921-A933428E-C489-42B4-B66D-9A8FB70BCD56

P5008

Q34043921-A692B17B-69AF-4EEB-B44A-2E5A09578692

P577

Q34043921-C7CE299B-3DF3-4917-9707-558EF065A63D

P5875

Q34043921-2EB15A8D-707D-4945-B357-6D82657AD1FE

P6179

Q34043921-219D26B5-F50A-4674-A081-2D739253DE33

P698

Q34043921-064BA040-2B26-4860-B3D4-E342E3B40E93

P921

Q34043921-97D906D5-0BC9-490E-BFF5-98C8BBC6A347

Q34043921-A79D20C7-1FCC-4C97-A455-4088BAE3E194

P932

Q34043921-61A07016-8DC1-4FB2-98C6-F3A33026072D

P356

1475-2875-10-292

P1433

Malaria Journal

P1476

Use of mefloquine in children ...... inetics and tolerability data.

@en

P2093

Hans-Georg Rhein

http://www.w3.org/2001/XMLSchema#string

Loredana Regep

http://www.w3.org/2001/XMLSchema#string

Martin T Schaerer

http://www.w3.org/2001/XMLSchema#string

Miriam Adamcova

http://www.w3.org/2001/XMLSchema#string

Sudhir Bansod

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

The position of mefloquine as a 21st century malaria chemoprophylaxis

Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients

Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.

Choice of therapy for imported cases of falciparum malaria in children: a retrospective study of 100 cases seen in Marseilles, France.

A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children.

Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria

A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.

Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.

Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.

Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome

P2888

1475-2875-10-292

P304

292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-10-292

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Schlagenhauf

P5008

P577

2011-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51701523

http://www.w3.org/2001/XMLSchema#string

P6179

1013601514

http://www.w3.org/2001/XMLSchema#string

P698

21981927

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

3215676

http://www.w3.org/2001/XMLSchema#string